AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 18 filers reported holding AZIYO BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | +33.3% | 547 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | 0.0% | 547 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | -66.7% | 547 | -57.9% | 0.00% | – |
Q3 2021 | $9,000 | -92.0% | 1,300 | -89.0% | 0.00% | -100.0% |
Q2 2021 | $113,000 | -30.7% | 11,800 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $163,000 | +1.2% | 11,800 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $161,000 | – | 11,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 1,655,184 | $3,906,234 | 2.93% |
PERKINS CAPITAL MANAGEMENT INC | 348,948 | $824 | 0.72% |
Prosight Management, LP | 648,850 | $1,531,286 | 0.23% |
Indie Asset Partners, LLC | 26,500 | $62,540 | 0.07% |
Knollwood Investment Advisory, LLC | 58,962 | $139,150 | 0.05% |
Verdence Capital Advisors LLC | 14,410 | $34,008 | 0.00% |
Alyeska Investment Group, L.P. | 214,343 | $505,849 | 0.00% |
BerganKDV Wealth Management, LLC | 4,000 | $9,440 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 500 | $1,180 | 0.00% |